blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1133283

EP1133283 - A METHOD OF PRODUCING DRUG PARTICLES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.08.2005
Database last updated on 24.04.2024
Most recent event   Tooltip26.07.2013Lapse of the patent in a contracting statepublished on 28.08.2013  [2013/35]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2001/38]
Inventor(s)01 / BOISSIER, Catherine
AstraZeneca R&D Mölndal
S-431 83 Mölndal / SE
02 / JUPPO, Anne, Mari
AstraZeneca R&D Mölndal
S-43183 Mölndal / SE
 [2001/38]
Representative(s)Larsson, Birgitta, et al
AstraZeneca AB
Intellectual Property, Patents
151 85 Södertälje / SE
[N/P]
Former [2004/10]Larsson, Birgitta, et al
AstraZeneca AB, Intellectual Property, Patents
151 85 Södertälje / SE
Former [2001/38]Nelson, Michael Andrew
AstraZeneca Global Intellectual Property: Patents P.O. Box 272 - Mereside Alderley Park
Macclesfield, Cheshire SK10 4GR / GB
Application number, filing date99963729.122.11.1999
[2001/38]
WO1999SE02152
Priority number, dateSE1998000400323.11.1998         Original published format: SE 9804003
[2001/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0030612
Date:02.06.2000
Language:EN
[2000/22]
Type: A1 Application with search report 
No.:EP1133283
Date:19.09.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2000 takes the place of the publication of the European patent application.
[2001/38]
Type: B1 Patent specification 
No.:EP1133283
Date:06.10.2004
Language:EN
[2004/41]
Search report(s)International search report - published on:SE02.06.2000
ClassificationIPC:A61K9/14, A61K31/41, A61K31/44, A61K31/165
[2001/38]
CPC:
A61K9/14 (EP,US); A61K31/167 (EP,US); A61K31/454 (EP,US);
A61K9/1688 (EP,US); B01D11/0411 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/38]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON ARZNEISTOFFPARTIKELN[2001/38]
English:A METHOD OF PRODUCING DRUG PARTICLES[2001/38]
French:PROCEDE DE PRODUCTION DE PARTICULES MEDICAMENTEUSES[2001/38]
Entry into regional phase25.06.2001National basic fee paid 
25.06.2001Designation fee(s) paid 
25.06.2001Examination fee paid 
Examination procedure23.05.2000Request for preliminary examination filed
International Preliminary Examining Authority: SE
25.06.2001Examination requested  [2001/38]
14.08.2003Despatch of a communication from the examining division (Time limit: M06)
19.02.2004Reply to a communication from the examining division
14.04.2004Communication of intention to grant the patent
19.07.2004Fee for grant paid
19.07.2004Fee for publishing/printing paid
Opposition(s)07.07.2005No opposition filed within time limit [2005/39]
Fees paidRenewal fee
07.11.2001Renewal fee patent year 03
07.11.2002Renewal fee patent year 04
07.11.2003Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9003782  (UPJOHN CO [US]);
 [Y]WO9619198  (ASTRA AB [SE], et al);
 [X]WO9714407  (RES TRIANGLE PHARM LTD [US], et al);
 [A]WO9828294  (ASTRA AB [SE], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.